---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-103799"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:14:54.413588+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma approves performance incentive plan contingent on $1B market cap by Dec 31, 2027

## Summary
- Plan grants up to 1% of outstanding shares, capped at $10M total and $1M per recipient.
- Effective only if ABVC maintains $1B market cap for 30 consecutive trading days before 2027 deadline.
- Shares come from Amended 2016 Equity Incentive Plan; allocation set by Compensation Committee and Board.
- No guarantee the condition will be met; plan may never be implemented.

## SEC filing metadata
- accession: 0001213900-25-103799
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390025103799/0001213900-25-103799-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025103799/ea0262960-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-103799
- JSON: https://secwatch.observer/filing/0001213900-25-103799.json
- Plain text: https://secwatch.observer/filing/0001213900-25-103799.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.